- Home
- CTNM vs BRLS Comparison
CTNM vs BRLS Comparison
Compare CTNM & BRLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- BRLS
- Stock Information
- Founded
- CTNM 2009
- BRLS 2019
- Country
- CTNM United States
- BRLS Canada
- Employees
- CTNM N/A
- BRLS N/A
- Industry
- CTNM
- BRLS
- Sector
- CTNM
- BRLS
- Exchange
- CTNM Nasdaq
- BRLS NYSE
- Market Cap
- CTNM 122.9M
- BRLS 130.4M
- IPO Year
- CTNM 2024
- BRLS N/A
- Fundamental
- Price
- CTNM $4.76
- BRLS $4.75
- Analyst Decision
- CTNM Strong Buy
- BRLS
- Analyst Count
- CTNM 4
- BRLS 0
- Target Price
- CTNM $22.50
- BRLS N/A
- AVG Volume (30 Days)
- CTNM 128.0K
- BRLS 142.9K
- Earning Date
- CTNM 08-12-2025
- BRLS 08-13-2025
- Dividend Yield
- CTNM N/A
- BRLS N/A
- EPS Growth
- CTNM N/A
- BRLS N/A
- EPS
- CTNM N/A
- BRLS N/A
- Revenue
- CTNM N/A
- BRLS $26,619,131.00
- Revenue This Year
- CTNM N/A
- BRLS N/A
- Revenue Next Year
- CTNM N/A
- BRLS N/A
- P/E Ratio
- CTNM N/A
- BRLS N/A
- Revenue Growth
- CTNM N/A
- BRLS N/A
- 52 Week Low
- CTNM $3.35
- BRLS $3.00
- 52 Week High
- CTNM $22.00
- BRLS $9.47
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- BRLS 48.52
- Support Level
- CTNM N/A
- BRLS $4.45
- Resistance Level
- CTNM N/A
- BRLS $6.26
- Average True Range (ATR)
- CTNM 0.00
- BRLS 0.93
- MACD
- CTNM 0.00
- BRLS 0.10
- Stochastic Oscillator
- CTNM 0.00
- BRLS 36.64
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About BRLS BOREALIS FOODS INC
Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.